Search

Chinese
Resource Library / In Vitro ADME Services

fact-sheet

In Vitro ADME Services

Frontage Global Drug Discovery Services (GDDS) offers a full spectrum of in vitro ADME assays for small molecule drug discovery and preclinical development. Our strong focus on lab operations, automation, and project management enables efficient delivery and unparalleled quality. We believe in a customer-centric approach providing real-time communication and reliable consultations to Sponsors.

Resources to Consider

Left arrow
In Vitro Cardiac Safety Evaluation
fact-sheet

In Vitro Cardiac Safety Evaluation
The FDA and the ICH S7B provide guidelines for assessing cardiac safety. In Vitro Assays a...
Access Resource
IN Vitro Assessment of the inhibition of Human Organic Anion Transporting Polypeptide 1B1/1B3 by Highly Bound Plasma Proteins Compounds in the Presence of Physiological Concentration of Human Serum Albumin 
poster

IN Vitro Assessment of the inhibition of Human Organic Anion...
The present study was aimed to validate this alternate approach to assess inhibition of or...
Access Resource
In Vitro BE Study in ANDA Drug Product Development
podcast

In Vitro BE Study in ANDA Drug Product Development
In this podcast, we talk about an in vitro bioequivalence (BE) Study in ANDA drug developm...
Access Resource
Stability Study for EMLA Cream Using In Vitro Percutaneous Absorption
poster

Stability Study for EMLA Cream Using In Vitro Percutaneous Absorption
EMLA Cream (lidocaine 2.5% and prilocaine 2.5%) is an emulsion in which the oil phase is a...
Access Resource
An Unexpected Major Circulating Metabolite M219 Detected in 14C-labeled Human ADME Study of  Brilaroxazine
poster

An Unexpected Major Circulating Metabolite M219 Detected in...
At Frontage Laboratories, a systematic method development approach has been established by...
Access Resource
WebninarAnalytical Challenges for CMC Development of Cell and Gene Therapy ProductsWebninar
webinar

WebninarAnalytical Challenges for CMC Development of Cell and Gene...
In this webinar we will cover:
Innovative solutions and best practices for accelera...
Access Resource
Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using the Simoa HD-X platform
poster

Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using...
Alzheimer’s disease (AD) is a neurodegenerative disorder which stands as one of the most...
Access Resource
Addressing the Increasing Needs of Data Integrity by Implementing the ElectronicSystems in a Paperless Bioanalytical Laboratory
Access Resource
Nonclinical Vehicle Formulations:HP-β-CD (Hydroxypropyl-Beta-Cyclodextrin) & The Risk of Hemolysis
poster

Nonclinical Vehicle Formulations:HP-β-CD...
Beta-cyclodextrin is a commonly used excipient in nonclinical vehicle formulations. In a r...
Access Resource
Evaluating the feasibility of lyophilization for oral formulation development of monoclonal antibodies (mAbs)​
poster

Evaluating the feasibility of lyophilization for oral formulation...
Objective: To develop a stable lyophilized non-invasive oral formulation of monoclonal ant...
Access Resource
A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
poster

A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication...
Lentiviral vectors are widely used in gene and cell therapy for diseases like HIV, cancer,...
Access Resource
Identification of the Major Circulating Metabolite of Mymd-1 And Elucidation of the Mechanism of Clearance of MYMD-1 in Humans. Role of Aldehyde Oxidase and CYP2A6
poster

Identification of the Major Circulating Metabolite of Mymd-1 And...
MYMD-1 is an immunomodulator that is currently entering Phase II clinical development for ...
Access Resource
Right arrow